Introduction
Pulmonary surfactant is a complex mixture of phospholipids and proteins. The major protein component, surfactant protein-A (SP-A), is a 34-36 kDa member of the calciumdependent lectin family of proteins that facilitates the surface tension-lowering properties of surfactant phospholipids in the alveolus, regulates surfactant phospholipid synthesis, secretion, and recycling, and also plays an important role in pulmonary host defense (18) . The mechanism of SP-A binding to lung type II cells is not completely understood, yet it appears to be critical for the cell-associated functions of SP-A. Binding of SP-A to type II cells was found both saturable and specific, suggesting that this interaction is mediated through a receptor on the cell surface (24, 55).
Thus far investigators have identified SP-A receptor(s) by utilizing either anti-idiotypic
antibodies (43, 46) or SP-A affinity column chromatography (9, 21) . Using an idiotypic approach, one group has identified three proteins with apparent M r of 30, 52, and 60 kDa (44) and the 30-kDa protein was shown to be associated with the regulation of secretagoguestimulated surfactant secretion (45, 46) ). On the other hand, another group using similar strategy identified a 55-kDa protein (43) shown to be involved in surfactant endocytosis by type II cells (53, 55) . Using ligand affinity chromatography, three proteins with apparent M r of 65, 55, and 50 kD were identified by a third group on type II cell surface and the 50 kDa protein was shown to be involved in phospholipid uptake (21). A fourth group described a SP-A receptor from U937 macrophages with a molecular mass of 210 kDa using SP-A affinity column chromatography (9) . This receptor was detected in both alveolar macrophages and type II epithelial cells and was found to block the SP-A-mediated inhibition of phospholipid secretion by type II cells. From the these studies, it seems that the SP-A receptor(s) on type II cell surface Identification of P63-Gupta et al.
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Material and Methods

Isolation of pneumocytes
Type II cells were isolated from adult male Sprague-Dawley rat lungs according to the procedure of Dobbs et al. (11) as previously described (7, 8) . Briefly, after perfusion via the pulmonary artery and lavage through a tracheal cannula, the lungs were digested with elastase and minced in the presence of DNase (Sigma-Aldrich) and fetal bovine serum (ICN Biochemicals). The cells were separated by filtration and enriched for type II cells by plating on rat IgG (Sigma-Aldrich) coated petri dishes that served to remove most contaminating macrophages. After overnight culture and removal of nonadhered cells, the purity of the type II cell preparation was 90-98%.
Type II cells were isolated from C57Bl6 mouse lungs using dispase as described previously (6, 50, 52) . Briefly, perfused lungs were digested with dispase, treated with DNAase I and filtered through nylon mesh (100 µm, 40 µm, and 25 µm size). Macrophages were removed from the cell preparation by plating on mouse IgG-coated Petri dishes. The nonadherent cells were seeded on 100 mm cell culture dishes in 10% FBS at 37 o C for 1 h twice to remove fibroblasts. The final cell isolates were seeded on Type I collagen-coated 35 mm dishes in Ham's F12 culture medium supplemented with 15 mM HEPES, 0.8 mM CaCl 2 , 0.25% BSA, 5 µg/ml insulin, 5 µg/ml transferrin, 5 ng/ml sodium selinite, and 2% mouse serum. After 24 h, more than 95% of the isolated cells were type II cells.
Alveolar macrophages were isolated by bronchoalveolar lavage and centrifugation. The resultant preparation was > 98% macrophages (3). A immobilized agarose beads (Sigma) were added to the supernatant and incubated for 6 hrs in cold. After washing the beads three times with RIPA buffer, the bound proteins were eluted from the agarose beads by incubation and boiling with Laemmli (25) sample buffer in the presence 2-mercaptoethanol. The eluted proteins were loaded onto 4-12% Bis-Tris gradient SDS-PAGE gels (Invitrogen) for electrophoresis followed by Western blotting. To investigate the interaction of P63 and SP-A in solution, co-immunoprecipitation experiments were performed as described above using protein A-agarose beads, rabbit antihuman SP-A (Chemicon), rabbit anti-human P63 or mouse anti-human P63 (40) antibodies.
SDS-PAGE and Western blotting
Proteins from the cell lysates or cross-linked samples were resolved on 3-8% Inc, PA) for 1 hr at room temperature at a dilution of 1: 5000. Membranes were scanned on the Odyssey infrared scanner after 5 washes in TBST buffer.
Mass spectrometry and Database search
SDS-PAGE gels were stained with mass spectrometry compatible silver stain (Silver Quest from Invitrogen) and the bands were excised. The gel pieces were washed, reduced, alkylated and digested in situ with trypsin. Peptides thus generated were injected into a nano capillary reverse phase HPLC coupled to a nano-electrospray ionization source of ThermoFinnigan LCQ quadrupole ion trap mass spectrometer. This mass spectrometer measured peptide masses and then fragmented individual peptides to produce MS/MS spectra of fragments that reflected the peptide sequence. The MS/MS spectra were run against NCBI non-redundant database. The resulting MS/MS matches and sequences were than reviewed for the fidelity of the matched spectra. This analysis was performed at the Wistar Institute Proteomics Facility of the University of Pennsylvania.
Purification of SP-A
Bronchoalveolar lavage fluid was obtained from lungs of alveolar proteinosis patients following therapeutic lavage at the Hospital of the University of Pennsylvania. Cellular material was removed by centrifugation, and surfactant was purified by density gradient centrifugation, followed by dialysis and lyophilization as described previously (2) . We obtained SP-A extraction, dialysis, and microconcentration, as described (2) . The purity of the SP-A preparation was monitored by SDS-PAGE (25).
Preparation of Liposomes
Lipids were obtained from Avanti Polar Lipids (Birmingham, AL). Unilamellar liposomes were prepared from DPPC, egg PC, egg phosphatidylglycerol, and cholesterol (molar ratio, 10:5:2:3) using "The Extruder" (Lipex Biomembranes) according to the directions of the manufacturer.
Phosphatidylcholine (PC) secretion
After isolation, type II cells were incubated overnight with 0. and/or Alexa 594 (red) labeled goat anti-mouse or -rabbit IgG (Molecular Probes) at room temp for 1 h. Thereafter, samples were observed under a confocal microscope (Bio-Rad).
Statistics.
Data is reported as mean + S.E. Statistical comparisons were performed with SigmaStat (Jandel Scientific) using using a standard t-test. Results were reported as statistically significant differences at P values < 0.05. 
Results
Identification of SP-A receptor by chemical cross-linking
Chemical cross-linking followed by mass spectrometric analysis of the cross-linked species has been utilized successfully to elucidate ligand-receptor interactions (17, 50, 51) . We Table 1 ). The six peptide sequences from a single database entry showed 100% match to the MS/MS spectra and confirmed the protein identity at a high confidence level. The 63 kDa protein band in the cross-linked complex was labeled with the polyclonal anti-P63 antibody (Fig. 2C , Lane 2), thus confirming the identity of the protein as P63/ERGIC 63.
Co-immunoprecipitation of P63 and SP-A
Protein-protein interaction between P63 and SP-A in vitro were studied by coimmunoprecipitation using rabbit polyclonal antibody to SP-A or mouse monoclonal antibody to P63. Anti-SP-A antibody immunoprecipitated P63 from rat type II cell lysates ( Figure 3A , Top).
Re-probing of the same blot with SP-A antibody showed a very strong 50-60 kDa band in the was present in the plasma membranes of A549 cell, a human lung adenocarcinoma with some type II cell characteristics (Fig 5B) . Caveolin 1 is a protein enriched in the plasma membrane and is commonly used to validate the identity of this fraction. Although type II cells do not have caveolin, the plasma membrane fraction from the A549 cells contained caveolin (Fig 5B) . ATP-stimulated PC secretion from type II cells. Neither mAb P63 (Fig 9A and B) nor nonimmune IgG (Fig 9B) affected basal or ATP-stimulated PC secretion when incubated with type II cells in the absence of added SP-A. P63 mAb inhibited the ability of SP-A to block secretagogue stimulated PC secretion in a dose-dependent manner ( Figure 9A ). SP-A (0.1 ug/ml) reduced ATP-stimulated PC secretion by 67%. Addition of mAb P63 resulted in a concentration dependent reversal of the effect of SP-A on stimulated secretion (Fig 9A) . At 100 ug mAb/ml, the reversal of the SP-A affect was 50% while IgG had no effect (Fig. 9B) .
Discussion
Earlier investigators have identified receptor(s) for SP-A using various approaches. The (38, 41) . It was originally suggested that P63 is a resident protein of a membrane network interposed between the rough ER and Golgi apparatus or the ERGIC compartments (38, 39) . Antibodies against ERGIC 63/P63 were first generated to elucidate the structural organization of the ER-to-Golgi pathway and to study the dynamics of its membrane elements (38, 40) . The distribution of P63 was shown to overlap with the ER-Golgi protein and P63 described in the current work. One contradictory point is that P63 does not seem to be a subunit of a larger protein complex as it remains at 63 kDa in both reduced and nonreduced gels. In our previous work using ligand blots with labeled A2R and SP-A, the bands of 30 and 60 kDa were labeled in reduced gels while a 210 kDa protein was labeled in non-reduced gels (7) indicating that the smaller proteins were components of a larger disulfide-bonded complex.
It has been demonstrated that although all three domains of the P63 protein are required to achieve complete intracellular retention, the cytoplasmic domain plays a dominant role. A truncation mutant of P63 which lacks this domain, 2-101AA has been shown to traffic exclusively to plasma membrane (40) . COS-1 cell transfected with this mutant led to an increase in tPA (tissue plasminogen activator)-catalyzed plasminogen activation and thus served as the functional binding site for tPA on the surface of vascular smooth muscle cells (35).
The pathway whereby P63 reaches the plasma membrane is unclear; previous studies on trafficking and localization have shown subdomain-specific localization of P63 in the endoplasmic reticulum mediated by its luminal alpha-helical segment (20) and its possible role in the positioning of the rough ER along microtubules (13, 19) . As discussed elsewhere, it is indeed possible that small pool of P63, when overexpressed, loses its association with microtubules and escapes its sub-domain-specific localization, freeing it to reach the plasma membrane (35). Another possibility is that P63 reaches the plasma membrane due to interactions with adaptor proteins such as 14-3-3. 
